Looking back on the year 2020, RIMLS organised a special webinar. In this RIMLS online New Year Celebration, scientific director René Bindels reviewed 2020 together with Clasien Oomen and Dagmar Eleveld-Trancikova and looked forward to 2021. In this live show, Frank van de Veerdonk pitched his Corona research experience and Marije Koenders presented a pitch about Team Science in the studio. Most importantly, a number of our researchers received prizes in the traditional RIMLS awards ceremony.
Otto Boerman representing the Jury, disclosed the secrets of the nominees, which have led to the award winners of the Best Master & PhD thesis. Marieke Willemse, as a virtual guest speaker, told us more about the Best Image award and success story to achieve this and Anouk Becker (chair RIMLS PhD Council) announced the honorable and highly desired RIMLS award: Supervisor of the Year!
To view this webinar click here.
The RIMLS award winners are:
RIMLS Master Thesis: Mara Nicolasen Major Histocompatibility Complex- class I drives polarisation of the microtubule organizing center in dendritic cell synapses
RIMLS PhD Thesis of 2020: Rik Lindeboom Investigating gene regulation in development and disease using integrative omics approaches
RIMLS Breakthrough Publication of 2020: Rebecca Halbach et al. (link) A satellite repeat-derived piRNA controls embryonic development of Aedes
Best RIMLS Image award: Daan ‘t Hart en Valentina Palacio-Castañeda
RIMLS Travel Grants:
|Cansu Yanginlar||€ 445,- to visit a conference Tübingen/Germany|
|Daan Vieringa||€ 1000,- to visit a conference in San Diego, CA, USA|
|Gijs Franken||€ 900,- to visit a conference in Andover, NH, USA|
|Lotte Tholen||€ 475,- to visit a workshop in Santander, Spain|
|Elke Muntjewerff||€ 500,- for a work placement at Uppsala University, Uppsala, Sweden|
|Teodora-Veronica Grigore||€ 500,- for a work placement at Karolinska Institute Stockholm, Sweden|
Supervisor of the Year:
The supervisor of the year award is organized by the RIMLS PhD Council. For 2020 Jeroen de Baaij, Ellen van den Boogaard and Frank Hoentjen were the three nominated supervisors. All RIMLS PhD candidates were invited to vote for these nominees. After an exciting neck-to-neck race Frank Hoentjen, theme Inflammatory Diseases, was elected as Supervisor of the Year 2020!
Annual RIMLS Award 2020: Otto Boerman Director of the Radboud Animal Research Facility
The RIMLS award is an annual prize for people who have contributed a lot to the RIMLS institute. Since 2017 Otto Boerman is the Director of the Radboud Animal Research Facility and transformed this facility into a financially healthy institute. More importantly, customer and staff satisfaction has increased enormously, giving the Radboud Technology Center (RTC) a new future. In addition, as chair of the RTC board, he further improved the organization of the RTC's. We are proud to have Otto Boerman as our colleague.
Want to know more about these subjects? Click on the buttons below for more news.
RIMLSNanomedicine Cancer development and immune defenseRare cancersTumors of the digestive tract Urological cancersWomen's cancersInfectious diseases and global healthInflammatory diseases Metabolic disordersReconstructive and regenerative medicineRenal disorders Vascular damage
Related news items
Nijmegen literally puts Digital Health on the map Flourishing ecosystem gets its own interactive overview22 July 2021
Digital Health is thriving in the Nijmegen region, where it contributes to better care and health and also creates jobs. To bring developers and end users even closer together, The Economic Board and the Radboudumc are introducing the Interactive Digital Health map.read more
Michiel Vermeulen and Klaas Mulder receive funding from ZonMw for a collaborative project using stem cell-based models15 July 2021
Michiel Vermeulen and Klaas Mulder, theme Cancer development and immune defense, receive funding from ZonMw for a collaborative project to develop a stem cell based model to study early human embryogenesis.read more
Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development15 July 2021
The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiative (IMI), a public-private European Research & Development Consortiumread more